Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy

Allergic diseases are among the most common health issues worldwide. Specific immunotherapy has remained the only disease-modifying treatment, but it is not effective in all patients and may cause side effects. Over the last 25 years, allergen molecules from most prevalent allergen sources have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Marth, Katharina, Focke-Tejkl, Margarete, Lupinek, Christian, Valenta, Rudolf, Niederberger, Verena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Specific Immunotherapy (L Cox, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025905/
https://www.ncbi.nlm.nih.gov/pubmed/24860720
http://dx.doi.org/10.1007/s40521-013-0006-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025905/
https://www.ncbi.nlm.nih.gov/pubmed/24860720
http://dx.doi.org/10.1007/s40521-013-0006-5

Ejemplares similares